Belite Bio, Inc Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() AADI
Aadi Bioscience, Inc. |
$3.41 | $42.72 M | -0.68 | 53 | $24.35 M |
![]() ACRV
Acrivon Therapeutics, Inc. Common Stock |
$6.79 | $223.86 M | -2.51 | 58 | $0 |
![]() ADAG
Adagene Inc. |
$1.98 | $131.46 M | -6.77 | 174 | $18.11 M |
![]() ALGS
Aligos Therapeutics, Inc. |
$45.62 | $40.52 M | -0.51 | 68 | $3.95 M |
![]() ANAB
AnaptysBio, Inc. |
$15.30 | $640.07 M | -3.82 | 136 | $91.28 M |
![]() ANEB
Anebulo Pharmaceuticals, Inc. |
$1.62 | $56.28 M | -5.86 | 2 | $0 |
![]() ANTX
AN2 Therapeutics, Inc. |
$1.38 | $60.55 M | -0.81 | 41 | $0 |
![]() AVTE
Aerovate Therapeutics, Inc. |
$2.70 | $597.48 M | -6.84 | 30 | $0 |
![]() CELC
Celcuity Inc. |
$13.17 | $501.59 M | -5.14 | 55 | $0 |
![]() CNTA
Centessa Pharmaceuticals plc |
$16.74 | $884.24 M | -6.2 | 75 | $6.85 M |
![]() GLTO
Galecto, Inc. |
$5.54 | $13.97 M | -0.46 | 13 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() IKNA
Ikena Oncology, Inc. |
$1.66 | $84.45 M | -1.11 | 14 | $0 |
![]() IMRX
Immuneering Corporation |
$2.36 | $40.63 M | -0.74 | 66 | $0 |
![]() LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() MOLN
Molecular Partners AG |
$5.06 | $135.05 M | -2.03 | 158 | $4.97 M |
![]() PMVP
PMV Pharmaceuticals, Inc. |
$1.57 | $85.40 M | -1.26 | 47 | $0 |
![]() TRDA
Entrada Therapeutics, Inc. |
$18.05 | $531.37 M | 22.81 | 183 | $210.78 M |
![]() VIGL
Vigil Neuroscience, Inc. |
$1.80 | $172.89 M | -2.17 | 66 | $0 |